-
Tata India Pharma & Healthcare Fund Regular Growth
Equity healthcare
Overview ( as on 20/12/24 )
NAV
₹30.82
Last change
₹-0.25 -0.01%
Fund Size (AUM)
1208.05 Cr
Performance
27.39% (5Y)
Fund Details
Tata India Pharma & Healthcare Fund Regular Growth
as of 20/12/24
AUM
1208.05 Cr
Expense Ratio
2.14 %
Benchmark
Nifty Pharma TR INR
ISIN
INF277K016A9
Fund Manager
Meeta Shetty
Exit Load
0.25% if redeemed within 0-30 days
0% if redeemed after 30 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Tata India Pharma & Healthcare Fund Regular Growth | 42.34% | 22.77% | 27.39% |
| Nifty Pharma TR INR | 43.76% | 19.63% | 26.27% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
12.31% |
Aurobindo Pharma Ltd |
8.57% |
Lupin Ltd |
7.43% |
Dr Reddy's Laboratories Ltd |
6.48% |
Cipla Ltd |
6.29% |
Divi's Laboratories Ltd |
5.12% |
Fortis Healthcare Ltd |
4.42% |
Zydus Lifesciences Ltd |
3.91% |
Alkem Laboratories Ltd |
3.6% |
Apollo Hospitals Enterprise Ltd |
3.42% |
Sector Allocation
Healthcare |
97.73% |
Basic Materials |
2.27% |
Asset Allocation
-
96%
Equity
-
4%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
30.29% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
29.28% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
29.28% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
27.43% (5Y)
-
-
DSP Healthcare Fund Reg Gr
Equity healthcare-
Returns
-
30.74% (5Y)
-
-
Tata India Pharma & Healthcare Reg Gr
Equity healthcare-
Returns
-
27.39% (5Y)
-
